ArticleFrontiers in pharmacology2020

Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer.

Mariana Alves Reis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.